Business Context and Reporting Period
This Form 8-K was filed by Catalyst Biosciences, Inc. on March 2, 2018, reporting on events occurring on March 1, 2018. The filing announces the Company's financial results for the fourth quarter and full year ended December 31, 2017. The registrant is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release attached as Exhibit 99.1, which is incorporated by reference but not included in the source text.
Material Changes
No specific material changes versus prior periods are quantified in the provided text. The filing serves as a notification that the fourth quarter and full-year 2017 results have been announced.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the financial results information in this Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that section and will not be incorporated into any registration statement unless expressly referenced. No specific guidance, outlook, or risk factors are detailed in the text provided.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2017 financial figures.
- Verify the Company's cash position and burn rate given the lack of revenue data in the summary.
- Confirm the status of the Company's emerging growth company election and its impact on financial reporting standards.
- Check for any subsequent filings that may incorporate the financial results by specific reference.